{
    "patient_info": "Depression,Hepatic cysts,Hepatosplenomegaly,Ascites,Splenomegaly,Weight loss,Neutropenia,Leukopenia,Anemia,Reticulocytosis,Hepatomegaly,Abdominal distention,Generalized muscle weakness,Abnormality of the abdominal wall,Poor appetite,Poikilocytosis,Anomalous splenoportal venous system,Abnormality of the gallbladder,Increased megakaryocyte count,Vertebral hyperostosis,Pedal edema,Anisocytosis,Myelofibrosis,Abnormal urinary color,Reduced granulocyte CD55 level,Reduced granulocyte CD59 level,Decreased expression of GPI-anchored proteins on the cell surface,Abnormality of mesentery morphology",
    "golden_diagnosis": "阵发性睡眠性血红蛋白尿症/Paroxysmal nocturnal hemoglobinuria; PNH/Paroxysmal nocturnal hemoglobinuria/Paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿症/Paroxysmal nocturnal hemoglobinuria; PNH/Paroxysmal nocturnal hemoglobinuria/Paroxysmal nocturnal hemoglobinuria,Paroxysmal nocturnal hemoglobinuria 2,阵发性睡眠性血红蛋白尿症/Paroxysmal nocturnal hemoglobinuria; PNH/Paroxysmal nocturnal hemoglobinuria/Paroxysmal nocturnal hemoglobinuria",
    "predict_diagnosis": "Step 1: The patient's symptoms of depression, hepatic cysts, hepatosplenomegaly, ascites, splenomegaly, weight loss, neutropenia, leukopenia, anemia, reticulocytosis, hepatomegaly, abdominal distention, generalized muscle weakness, abnormality of the abdominal wall, poor appetite, poikilocytosis, anomalous splenoportal venous system, abnormality of the gallbladder, increased megakaryocyte count, vertebral hyperostosis, pedal edema, anisocytosis, myelofibrosis, abnormal urinary color, reduced granulocyte CD55 level, reduced granulocyte CD59 level, and decreased expression of GPI-anchored proteins on the cell surface suggest a range of rare diseases, including:\n1. Hereditary spastic paraparesis type 1B (HSP1B): This rare genetic disorder is characterized by progressive weakness and spasticity in the legs, as well as other symptoms such as depression, hepatic cysts, hepatosplenomegaly, ascites, splenomegaly, weight loss, neutropenia, leukopenia, anemia, reticulocytosis, hepatomegaly, abdominal distention, generalized muscle weakness, abnormality of the abdominal wall, poor appetite, poikilocytosis, anomalous splenoportal venous system, abnormality of the gallbladder, increased megakaryocyte count, vertebral hyperostosis, pedal edema, anisocytosis, myelofibrosis, abnormal urinary color, reduced granulocyte CD55 level, reduced granulocyte CD59 level, and decreased expression of GPI-anchored proteins on the cell surface.\n2. Hereditary spastic paraparesis type 2 (HSP2): This rare genetic disorder is characterized by progressive weakness and spasticity in the legs, as well as other symptoms such as depression, hepatic cysts, hepatosplenomegaly, ascites, splenomegaly, weight loss, neutropenia, leukopenia, anemia, reticulocytosis, hepatomegaly, abdominal distention, generalized muscle weakness, abnormality of the abdominal wall, poor appetite, poikilocytosis, anomalous splenoportal venous system, abnormality of the gallbladder, increased megakaryocyte count, vertebral hyperostosis, pedal edema, anisocytosis, myelofibrosis, abnormal urinary color, reduced granulocyte CD55 level, reduced granulocyte CD59 level, and decreased expression of GPI-anchored proteins on the cell surface.\n3. Hereditary spastic paraparesis type 3 (HSP3): This rare genetic disorder is characterized by progressive weakness and spasticity in the legs, as well as other symptoms such as depression, hepatic cysts, hepatosplenomegaly, ascites, splenomegaly, weight loss, neutropenia, leukopenia, anemia, reticulocytosis, hepatomegaly, abdominal distention, generalized muscle weakness, abnormality of the abdominal wall, poor appetite, poikilocytosis, anomalous splenoportal venous system, abnormality of the gallbladder, increased megakaryocyte count, vertebral hyperostosis, pedal edema, anisocytosis, myelofibrosis, abnormal urinary color, reduced granulocyte CD55 level, reduced granulocyte CD59 level, and decreased expression of GPI-anchored proteins on the cell surface.\n4. Charcot-Marie-Tooth disease type 1A (CMT1A): This rare genetic disorder is characterized by progressive weakness and wasting of the muscles in the legs, as well as other symptoms such as depression, hepatic cysts, hepatosplenomegaly, ascites, splenomegaly, weight loss, neutropenia",
    "predict_rank": "否"
}